1.A Clinicopathologic Study of Immature Teratoma of the Ovary.
Kyoung Yun SEO ; Soo Young HUR ; Sa Jin KIM ; Tae Cheol PARK ; Suk Nyun BAE ; Gu Taeg HAN ; Joon Mo LEE ; Sung Eun NAMKOONG ; Jong Sup PARK
Korean Journal of Obstetrics and Gynecology 2004;47(12):2389-2396
OBJECTIVE: In this retrospective study, we analyzed the clinical and pathological characteristics of immature teratoma of the ovary. METHODS: Between 1990 and 2003, 26 patients with immature teratoma of the ovary treated in the Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea were identified, and reviewed retrospectively for patient profiles, International Federation of Gynecologists and Obstetricians (FIGO) disease stage, mode of therapy, and length of survival. RESULTS: The mean and median age at diagnosis was 27.0 and 25.5 years (range 11-58 years), respectively. Tumors were 73.1% (19/26) stage I, 3.8% (1/26) stage II, 19.2% (5/26) stage III, and 3.8% (1/26) stage IV. Eighteen patients (69.2%) had pathologic grade 2 or 3. Twenty of 26 patients underwent the conservative surgery including unilateral salpingo-oophorectomy, unilateral oophorectomy or cystectomy, and other patients were performed the total abdominal hysterectomy with bilateral salpingo-oophorectomy. All except five patients received adjuvant combination chemotherapy. Second look operation following combination chemotherapy was done in nine cases. Two patients who had grade III tumors died. Follow-up was available for all the patients, with a mean duration of 43.9 months. No recurrence was observed during this period. CONCLUSION: Immature teratoma of the ovary is a potentially curable disease in today's practice. Low stage and low grade tumors have an excellent prognosis and conservative surgery and preservation of fertility is warranted in those cases.
Cystectomy
;
Diagnosis
;
Drug Therapy, Combination
;
Female
;
Fertility
;
Follow-Up Studies
;
Gynecology
;
Humans
;
Hysterectomy
;
Korea
;
Obstetrics
;
Ovariectomy
;
Ovary*
;
Prognosis
;
Recurrence
;
Retrospective Studies
;
Teratoma*
2.A case of reactive airway dysfunction syndrome due to chlorine gas exposure.
Kyoung Young NAMKOONG ; Ju Yeal BAEK ; Hye Suk SON ; Choon Hee CHANG ; Myeong Jin KANG ; Hong Mok LIM ; Yong Keun PARK ; Sang Rok LEE
Journal of Asthma, Allergy and Clinical Immunology 2003;23(4):842-845
The reactive airway dysfunction syndrome (RADS), a subset of irritant-induced asthma, has been described following exposure to various irritant gas. We describe a case of RADS occuring following a single exposure to high levels of chlorine gas in the workplace. No documented pre-existing respiratory illness and atopy was identified. Cough, dyspnea, and wheezing were developed with the single accidental exposure to chlorine gas and methacholine provocation test was positive. He was completely recovered with the treatment of corticosteroid and oxygen therapy.
Angioedema
;
Asthma
;
Cellulitis
;
Chlorine*
;
Cough
;
Dyspnea
;
Eosinophilia
;
Hypereosinophilic Syndrome
;
Methacholine Chloride
;
Oxygen
;
Respiratory Sounds
3.Identification of Gene Expression and Gene Ontology Classification by Differential Display RT-PCR in Human Cervical Squamous Cell Carcinoma.
Min Je SEO ; Su Mi BAE ; Kyoung Mi PARK ; Byung Hoon KIM ; Yong Wan KIM ; Kyuong Yun SEO ; Kyung A SEO ; Yong Wook KIM ; Soo Young HUR ; Duck Young RO ; Joon Mo LEE ; Sung Eun NAMKOONG ; Chong Kook KIM ; Woong Shick AHN
Korean Journal of Obstetrics and Gynecology 2004;47(4):684-694
OBJECTIVE: The molecular pathology of cervical cancer associated with human papillomavirus infection is presently unclear. In an effort to clarify the multiple interactions of a number of genes involved in cervical carcinogenesis, the gene expression profiles and pathogenic cellular processes between human cervical squamous cell carcinoma and normal cervix were investigated by mRNA differential display and the Gene Ontology analysis. METHODS: Cervical cancer biopsies were obtained from patients at the Department of Obstetrics and Gynecology, The Catholic University of Korea. The disease status was assigned according to the International Federation of Gynecology and Obstetrics. The squamous cell carcinoma tissue samples of 3 patients invasive cancer stage II (1), IV (2) were investigated by mRNA differential display. As a control, we used a common reference that was mixed with equal amount of RNA obtained from 17 normal cervix to obtain variation- independent control. Also, we constructed hierarchical functional structures using gene ontology. Then, the specific function groups were correlated with differential gene expression profiles. In addition, specific gene expression patterns in several tissue samples were investigated by using DDRT-PCR analysis. RESULTS: Differentially expressed 191 genes were identified in tumor samples. Of these genes, 128 were up-regulated and 63 were down-regulated above 1.5-fold. The gene expression profiles were classified into 46 mutually dependent function sets and organized into sub-function sets depending on the cervical cancer pathway, suggesting the potentially significant genes of unknown function affected by carcinogenesis pathway. The genes related to metabolism, signal transduction, and chaperon activity were significantly up-regulated. In contrast, significant down-regulations were shown in nucleic acid binding activity, tumor suppressor and structural activity. Reliable gene expression data shows the validation of profiling method for studying the cervical cancer-specific pathway. CONCLUSION: The specific functions assigned to each expressed gene were correlated with gene ontology for the establishment of a powerful cervical carcinogenesis pathway. The results suggest that the differentially regulated cellular process profiles have an important impact on discovery of pathogenic pathway in human cervical squamous cell carcinoma and provide the potentially significant genes of unknown function. Also, the gene ontology analysis can overcome the complexity of the expression profiles of mRNA differential display via a cellular process level approach. Thereby, a valuable prognostic candidate gene with real relevance to disease-specific pathogenesis can be found at the cellular process levels.
Biopsy
;
Carcinogenesis
;
Carcinoma, Squamous Cell*
;
Cervix Uteri
;
Classification*
;
Female
;
Gene Expression Profiling
;
Gene Expression*
;
Gene Ontology*
;
Gynecology
;
Humans*
;
Korea
;
Metabolism
;
Obstetrics
;
Papillomavirus Infections
;
Pathology, Molecular
;
RNA
;
Signal Transduction
;
Transcriptome
;
Uterine Cervical Neoplasms
4.Proteomic analyses of cervical cancer tissues by two-dimensional gel electrophoresis and mass spectrometry.
Sung Ha LEE ; Su Mi BAE ; Ok Kyoung KIM ; Hyun Jung KIM ; Eun Kyung PARK ; Hae Nam LEE ; Yong Wook KIM ; Duck Yeong RO ; Joon Mo LEE ; Sung Eun NAMKOONG ; Young Lae CHO ; Gye Hyun NAM ; Byung Don HAN ; Yong Wan KIM ; Chong Kook KIM ; Woong Shick AHN
Korean Journal of Obstetrics and Gynecology 2005;48(7):1686-1697
OBJECTIVE: Comparison of protein expressions by two-dimensional gel electrophoresis (2-DE) in normal cervix and squamous cell carcinoma tissues in Korean women. METHODS: Normal cervix and squamous cell carcinoma tissues were solubilized with 2-DE buffer and the first dimension of PROTEAN IEF CELL, isoelectric focusing (IEF), was performed using pH3-10 linear IPG strips of 17 cm. And then running 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and sliver stain. Scanned image was analyzed using PDQuest 2-D softwareTM. Protein spot spectrum was identified by assisted laser desorption/ionization-time of fighting (MALDI-TOF) and the protein mass spectrum identifications were performed by searching protein databases of Swiss-prot/TrEMBL, Mascot and MS-FIT. RESULTS: We found 9 up-regulation proteins (Alpha enolase, Keratin 19 type I, Keratin 20 type I, Keratin 13 type I, beta-actin, Aflatoxin B1 aldehyde reductase 1, Annexin A2, Squamous cell carcinoma antigen 2, unknown), 7 down-reguation proteins (Annexin 1, Myosin regulatory light chain 2, 14-3-3 protein epsilon, Heat shock 27 kDa protein, Hypothetical protein (DKFZP434C1715), Tumor necrosis factor receptor superfamily member 13B, Smoth muscle protein 22-alpha) and 6 up and down-regulation proteins (Tropomyosin 1, Tropomyosin 2, Tropomyosin 3, Serine (or cysteine) proteinase inhibitor, Phosphatidylinositol transfer protein alpha isoform, Src homology 3 domain-containing protein HIP-55) between normal cervix and squamous cell carcinoma cell tissues. CONCLUSION: 2-DE offers total protein expressions between normal cervix and squamous cell carcinoma cell tissues, and searching of differently expressed protein for the diagnostic markers of squamous cell carcinoma tissue.
14-3-3 Proteins
;
Actins
;
Aflatoxin B1
;
Aldehyde Reductase
;
Annexin A2
;
Carcinoma, Squamous Cell
;
Cervix Uteri
;
Databases, Protein
;
Down-Regulation
;
Electrophoresis, Gel, Two-Dimensional*
;
Electrophoresis, Polyacrylamide Gel
;
Female
;
Hot Temperature
;
Humans
;
Isoelectric Focusing
;
Keratin-13
;
Keratin-19
;
Keratin-20
;
Mass Spectrometry*
;
Muscle Proteins
;
Myosin Light Chains
;
Phospholipid Transfer Proteins
;
Phosphopyruvate Hydratase
;
Receptors, Tumor Necrosis Factor
;
Running
;
Serine
;
Shock
;
Sodium Dodecyl Sulfate
;
Tropomyosin
;
Up-Regulation
;
Uterine Cervical Neoplasms*
5.Development of Gene Therapy Strategy Using Plasmid and Adenovirus in Cervical Cancer Treatment.
Jun Mo LEE ; Seung Jo KIM ; Sung Eun NAMKOONG ; Sung Dae CHO ; Seong Jin HWANG ; Hyun Ra PARK ; You Jin HAN ; Sang Tae KIM ; Hun Young LEE ; Dong Jae KIM ; Yong Serk PARK ; Chong Kook KIM ; Yu Kyoung OH ; Soon Hee PARK ; Woong Shick AHN
Korean Journal of Obstetrics and Gynecology 1999;42(9):2019-2027
BACKGROUND: The basic treatment of malignant tumors is surgery, radiotherapy, chemotherapy. Even though, the object of these treatments is to kill cancer cells, they have limitations. So, in future studies of treatment of cancer, we should look into increasing human immune response using gene therapy in order to induce damage to tumor cells. OBJECTIVE: The cell growth inhibitory effect of cervical cancer cells was investigated by direct transfection using liposome(pRcCMVp53/lipofectin). and by indirect transfection using Adenovirus(AdCMVp53). METHODS: The cervical cancer cell lines we used in this study were HPV16 positive, having inhibitory gene, wild p53 gene, CaSki, SiHa, HPV18 positive HeLa, HeLaS3 and HPV negative C33A, HT3, LacZ gene was used as the marker gene for the transfection efficacy. Direct transfection was done by using lipofectin (pRcCMVp53/lipofectin) and indirect transfection was done by using virus, AdCMVp53. The effect of tumor cell growth inhibition was measured by cell counting assay. RESULT: Inhibition of growth of cervical cancer cells in cell counts of direct transfection was CaSki(88.5%), SiHa(59.1%), HeLa(86.0%), HeLaS3(78.0%), C33A(91.3%) and HT3(74.0%). Inhibition of growth of cervical cancer cells in cell counts of indirect transfection was CaSki(97.4%), SiHa(91.6%), HeLa(95.8%), HeLaS3(99.7%), C33A(97.3%) and HT3(87.4%). CONCLUSION: The inhibition of cell growth of cervical cancer cells by direct and indirect transfection was significantly reduced, and showed little differences depending on the type of cells. These results will have a great meaning in treating cervical cancer patients using gene therapy by direct or indirect transfection
Adenoviridae*
;
Cell Count
;
Cell Line
;
Drug Therapy
;
Genes, p53
;
Genetic Therapy*
;
Humans
;
Lac Operon
;
Plasmids*
;
Radiotherapy
;
Transfection
;
Uterine Cervical Neoplasms*
6.The Changes of Cell Cycle Regulatory Proteins Expression by AdCMVp53 in Cervical Cancer Cell Lines.
Dong Geun JIN ; Dong Hyun LEE ; Kyoung Yun SEO ; Sue Yeon KIM ; Seung Won HUH ; Su Mi BAE ; Young Wan KIM ; Keun Ho LEE ; Jun Mo LEE ; Sung Eun NAMKOONG ; Chong Kook KIM ; Woong Shick AHN
Korean Journal of Obstetrics and Gynecology 2003;46(11):2180-2188
OBJECTIVE: In this study, we investigated the cell growth inhibition, regulation of cell cycle and induction of apoptosis through recombinant p53 adenoviral vector delivery into cervical cancer cell line SiHa, to explore the possibility of p53 gene therapy. METHODS: We infected SiHa with AdCMVp53 at 50 MOI. After 48 hours, the regulation of cell cycle and apoptosis were investigated with FACS. The gene expression profiling associated with cell cycle was also investigated with cell cycle DNA membrane chip. RESULTS: SiHa cells were arrested in the G1 phase by AdCMVp53 and showed cell growth inhibition via apoptosis. The gene expression profiles involved in cell cycle including cyclin-dependent kinase inhibitor 1C (p57, Kip2), RAD9 (S.pombe) homolog, and MAD2 (mitoticarrest deficient, yeast, homolog)-like 2 were up-regulated by more than three-fold, as compared to control group. In contrast, 6 genes such as retinoblastoma-like 2 (p130), and cyclin H were down-regulated by more than three-fold. Several genes known as being differentially up- or down-regulated compared to control were confirmed by RT-PCR and Western blotting assays. CONCLUSION: The adenoviral p53 gene delivery into cervical cancer cell line, suggesting the possibility of p53 gene therapy in cervical neoplasia make the cell growth inhibition and changes of cell cycle-associated gene expression.
Apoptosis
;
Blotting, Western
;
Cell Cycle Proteins*
;
Cell Cycle*
;
Cell Line*
;
Cyclin H
;
Cyclin-Dependent Kinase Inhibitor p57
;
DNA
;
G1 Phase
;
Gene Expression
;
Gene Expression Profiling
;
Genes, p53
;
Membranes
;
Transcriptome
;
Uterine Cervical Neoplasms*
;
Yeasts